🇺🇸 FDA
Patent

US 10287334

Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain

granted A61KA61K38/00A61P

Quick answer

US patent 10287334 (Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61P, A61P25/00, A61P25/04